Protopic for maintenance therapy

The licensed indications for Protopic (tacrolimus) ointment have been extended to include maintenance therapy of moderate to severe atopic dermatitis for the prevention of flares and prolongation of flare-free intervals.

Maintenance treatment is suitable for patients experiencing a high frequency of disease exacerbations (occurring four or more times a year) who have had an initial response to a maximum of six weeks treatment of twice daily application of tacrolimus ointment. An initial response is defined as lesions cleared, almost cleared or mildly affected.

For maintenance the ointment should be applied once a day twice weekly with a gap of two to three days between applications. At the first signs of a recurrence (flare) of disease symptoms the treatment dose should be resumed. Maintenance therapy should be reviewed after 12 months.

View Protopic drug record

Further information: Astellas Pharma


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases